Sugarloaf Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Sugarloaf Wealth Management's BMY Position: Q4 2024 in Review
Sugarloaf Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 3% in Q4 2024, buying an estimated $4.47K and bringing the position to 2,737 shares worth $155K. The position accounts for 0.03% of the portfolio, ranked #196.
Sugarloaf Wealth Management first reported a position in BMY in Q4 2019 and has held it in 21 quarters since. The position peaked at $914K in Q4 2019. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.
- Sugarloaf Wealth Management held 2,737 shares of Bristol-Myers Squibb worth $155K as of Q4 2024.
- Sugarloaf Wealth Management bought 80 Bristol-Myers Squibb shares in Q4 2024, an estimated $4.47K.
- Bristol-Myers Squibb made up 0.03% of Sugarloaf Wealth Management's portfolio in Q4 2024, its #196 holding.
- Sugarloaf Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 21 quarters since.
- Sugarloaf Wealth Management's Bristol-Myers Squibb position peaked at $914K in Q4 2019.
- 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.
Based on Sugarloaf Wealth Management's 13F filing for Q4 2024, filed 10 Jan 2025.